AH Capital Management, L.L.C.
13F Reported Value
ⓘ$1.3B
Holdings
16
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
AH Capital Management, L.L.C. disclosed 16 positions worth $1.3B in its Form 13F-HR for Q1 2026, led by $NAVN (Navan, Inc.) at 28.9% of the equity portfolio, followed by $FIG and $META. During the quarter the fund opened 4 new positions and exited 1 — including a new stake in $DMRA and a full exit from $HTBK. The portfolio is most concentrated in Technology (74.6% of disclosed assets). All figures are sourced directly from AH Capital Management, L.L.C.’s Form 13F-HR filing with the SEC under CIK 1540358.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$373.6M28,218,676 sh - 45.2#1,730
Quality
$338.5M16,011,378 sh - 80.9#35
Quality
$121.6M212,531 sh - —
Quality
$89.6M921,099 sh - —
Quality
$68.5M17,653,917 sh - 60.3
Quality
$61.2M1,016,697 sh - 28.6
Quality
$56.5M3,233,170 sh - 19.7
Quality
$50.8M1,702,225 sh - —
Quality
$46.3M2,862,500 sh - —
Quality
$32.0M1,236,157 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Navan, Inc.$NAVN | — | $373.6M | 28,218,676 |
 Figma, Inc.$FIG | 45.2#1,730 | $338.5M | 16,011,378 |
 Meta Platforms, Inc.$META | 80.9#35 | $121.6M | 212,531 |
 Revolution Medicines, Inc.$RVMD | — | $89.6M | 921,099 |
 Nautilus Biotechnology, Inc.$NAUT | — | $68.5M | 17,653,917 |
 Block, Inc.$XYZ | 60.3 | $61.2M | 1,016,697 |
 BioAge Labs, Inc.$BIOA | 28.6 | $56.5M | 3,233,170 |
 Maze Therapeutics, Inc.$MAZE | 19.7 | $50.8M | 1,702,225 |
 Erasca, Inc.$ERAS | — | $46.3M | 2,862,500 |
 Damora Therapeutics, Inc.$DMRA | — | $32.0M | 1,236,157 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of AH Capital Management, L.L.C.'s 16 positions.
Showing top 10 of 16 holdings.
Sector Allocation
Technology
$963.4M
Healthcare
$321.7M
Financials
$5.5M
Other
$21,843
Full Holdings — AH Capital Management, L.L.C. (Q1 2026)
All 16 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $NAVN | Navan, Inc. | $373.6M | 28.9% | +4% | — |
| 2 | $FIG | Figma, Inc. | $338.5M | 26.2% | -1% | 45.2 |
| 3 | $META | Meta Platforms, Inc. | $121.6M | 9.4% | +0% | 80.9 |
| 4 | $RVMD | Revolution Medicines, Inc. | $89.6M | 6.9% | +0% | — |
| 5 | $NAUT | Nautilus Biotechnology, Inc. | $68.5M | 5.3% | +0% | — |
| 6 | $XYZ | Block, Inc. | $61.2M | 4.7% | +0% | 60.3 |
| 7 | $BIOA | BioAge Labs, Inc. | $56.5M | 4.4% | +0% | 28.6 |
| 8 | $MAZE | Maze Therapeutics, Inc. | $50.8M | 3.9% | +0% | 19.7 |
| 9 | $ERAS | Erasca, Inc. | $46.3M | 3.6% | +0% | — |
| 10 | $DMRA | Damora Therapeutics, Inc. | $32.0M | 2.5% | NEW | — |
| 11 |  $OMDA | Omada Health, Inc. | $29.0M | 2.3% | -33% | 45.5 |
| 12 |  $CAMP | Camp4 Therapeutics Corp | $9.4M | 0.7% | +0% | 23.3 |
| 13 |  $AKTS | Aktis Oncology, Inc. | $7.4M | 0.6% | NEW | — |
| 14 |  $BTGO | BITGO HOLDINGS, INC. | $5.5M | 0.4% | NEW | — |
| 15 |  $DNA | Ginkgo Bioworks Holdings, Inc. | $665,522 | 0.1% | +0% | 11.7 |
| 16 | — | IP STRATEGY HOLDINGS INC | $21,843 | 0.0% | NEW | — |
New Positions (4)
Exited Positions (1)
$HTBK HERITAGE COMMERCE CORPBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for AH Capital Management, L.L.C. including:
Track AH Capital Management, L.L.C.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for AH Capital Management, L.L.C. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: AH Capital Management, L.L.C.
13F Pro is an AI hedge fund tracker and stock research platform. For AH Capital Management, L.L.C. (SEC CIK: 1540358), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in AH Capital Management, L.L.C.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.